Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vibrio cholerae O139 is a serogroup of the bacterium Vibrio cholerae responsible for epidemic cholera. It is a gram-negative bacterium characterized by its unique O-antigen polysaccharide and polysaccharide capsule. It possesses key virulence factors such as cholera toxin (CTX), a type II secretion system, and biofilm formation genes, enabling it to cause severe diarrheal disease.
Antibiotics target essential bacterial processes, leading to cell death or growth inhibition. Rehydration therapy replenishes lost fluids and electrolytes.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vibrio cholerae O139.